United States Human Coagulation Factor VII Market by Manufacturers, States, Type and Application, Forecast to 2022

May 2017 | 115 pages | ID: U937AC192EFEN
GlobalInfoResearch

Abstracts

Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.

SCOPE OF THE REPORT:

This report focuses on the Human Coagulation Factor VII in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers

• NovoNordisk

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Market Segment by Type, covers

• Type 1
• Type 2

Market Segment by Applications, can be divided into

• Hemophilia Treatment
• Surgery
• Other

There are 17 Chapters to deeply display the United States Human Coagulation Factor VII market.

Chapter 1, to describe Human Coagulation Factor VII Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Human Coagulation Factor VII, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Human Coagulation Factor VII, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Human Coagulation Factor VII market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Human Coagulation Factor VII Research Findings and Conclusion, Appendix, methodology and data source.

Contents

1 MARKET OVERVIEW

1.1 Human Coagulation Factor VII Introduction
1.2 Market Analysis by Type
  1.2.1 Type
  1.2.2 Type
1.3 Market Analysis by Applications
  1.3.1 Hemophilia Treatment
  1.3.2 Surgery
  1.3.3 Other
1.4 Market Analysis by States
  1.4.1 California Status and Prospect (2012-2022)
  1.4.2 Texas Status and Prospect (2012-2022)
  1.4.3 New York Status and Prospect (2012-2022)
  1.4.4 Florida Status and Prospect (2012-2022)
  1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 NovoNordisk
  2.1.1 Profile
  2.1.2 Human Coagulation Factor VII Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 NovoNordisk Human Coagulation Factor VII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 NovoNordisk News

3 UNITED STATES HUMAN COAGULATION FACTOR VII MARKET COMPETITION, BY MANUFACTURER

3.1 United States Human Coagulation Factor VII Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Human Coagulation Factor VII Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Human Coagulation Factor VII Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Human Coagulation Factor VII Manufacturer Market Share
  3.4.2 Top 5 Human Coagulation Factor VII Manufacturer Market Share
3.5 Market Competition Trend

4 UNITED STATES HUMAN COAGULATION FACTOR VII MARKET ANALYSIS BY STATES

4.1 United States Human Coagulation Factor VII Sales Market Share by States
4.2 United States Human Coagulation Factor VII Sales by States (2012-2017)
4.3 United States Human Coagulation Factor VII Revenue (Value) by States (2012-2017)

5 UNITED STATES MARKET SEGMENTATION HUMAN COAGULATION FACTOR VII BY TYPE

5.1 United States Human Coagulation Factor VII Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 United States Human Coagulation Factor VII Sales and Market Share by Type (2012-2017)
  5.1.2 United States Human Coagulation Factor VII Revenue and Market Share by Type (2012-2017)
5.2 Type 1 Sales Growth and Price
  5.2.1 United States Type 1 Sales Growth (2012-2017)
  5.2.2 United States Type 1 Price (2012-2017)
5.3 Type 2 Sales Growth and Price
  5.3.1 United States Type 2 Sales Growth (2012-2017)
  5.3.2 United States Type 2 Price (2012-2017)

6 UNITED STATES MARKET SEGMENTATION HUMAN COAGULATION FACTOR VII BY APPLICATION

6.1 United States Human Coagulation Factor VII Sales Market Share by Application (2012-2017)
6.2 Hemophilia Treatment Sales Growth (2012-2017)
6.3 Surgery Sales Growth (2012-2017)
6.4 Other Sales Growth (2012-2017)

7 CALIFORNIA HUMAN COAGULATION FACTOR VII SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 California Human Coagulation Factor VII Revenue, Sales and Growth Rate (2012-2017)
7.2 California Human Coagulation Factor VII Sales and Market Share by Type
7.3 California Human Coagulation Factor VII Sales by Application (2012-2017)

8 NEW YORK HUMAN COAGULATION FACTOR VII SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 New York Human Coagulation Factor VII Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Human Coagulation Factor VII Sales and Market Share by Type
8.3 New York Human Coagulation Factor VII Sales by Application (2012-2017)

9 TEXAS HUMAN COAGULATION FACTOR VII SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Texas Human Coagulation Factor VII Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Human Coagulation Factor VII Sales and Market Share by Type
9.3 Texas Human Coagulation Factor VII Sales by Application (2012-2017)

10 FLORIDA HUMAN COAGULATION FACTOR VII SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

10.1 Florida Human Coagulation Factor VII Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Human Coagulation Factor VII Sales and Market Share by Type
10.3 Florida Human Coagulation Factor VII Sales by Application (2012-2017)

11 ILLINOIS HUMAN COAGULATION FACTOR VII SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

11.1 Illinois Human Coagulation Factor VII Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Human Coagulation Factor VII Sales and Market Share by Type
11.3 Illinois Human Coagulation Factor VII Sales by Application (2012-2017)

12 HUMAN COAGULATION FACTOR VII MARKET FORECAST (2017-2022)

12.1 United States Human Coagulation Factor VII Sales, Revenue and Growth Rate (2017-2022)
12.2 Human Coagulation Factor VII Market Forecast by States (2017-2022)
12.3 Human Coagulation Factor VII Market Forecast by Type (2017-2022)
12.4 Human Coagulation Factor VII Market Forecast by Application (2017-2022)

13 HUMAN COAGULATION FACTOR VII MANUFACTURING COST ANALYSIS

13.1 Human Coagulation Factor VII Key Raw Materials Analysis
  13.1.1 Key Raw Materials
  13.1.2 Price Trend of Key Raw Materials
  13.1.3 Key Suppliers of Raw Materials
  13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
  13.2.1 Raw Materials
  13.2.2 Labor Cost
  13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Human Coagulation Factor VII

14 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

14.1 Human Coagulation Factor VII Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Human Coagulation Factor VII Major Manufacturers in 2016
14.4 Downstream Buyers

15 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

15.1 Sales Channel
  15.1.1 Direct Marketing
  15.1.2 Indirect Marketing
  15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Human Coagulation Factor VII Picture
Table Product Specifications of Human Coagulation Factor VII
Figure United States Sales Market Share of Human Coagulation Factor VII by Types in 2016
Table Types of Human Coagulation Factor VII
Figure Type 1 Picture
Table Major Manufacturers of Type
Figure Type 2 Picture
Table Major Manufacturers of Type
Table United States Human Coagulation Factor VII Sales Market Share by Applications in 2016
Table Applications of Human Coagulation Factor VII
Figure Hemophilia Treatment Picture
Figure Surgery Picture
Figure Other Picture
Figure California Human Coagulation Factor VII Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Human Coagulation Factor VII Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Human Coagulation Factor VII Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Human Coagulation Factor VII Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Human Coagulation Factor VII Revenue (Million USD) and Growth Rate (2012-2022)
Table NovoNordisk Basic Information, Manufacturing Base and Competitors
Table NovoNordisk Human Coagulation Factor VII Type and Applications
Table NovoNordisk Human Coagulation Factor VII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Human Coagulation Factor VII Sales by Manufacturer (2016-2017)
Figure United States Human Coagulation Factor VII Sales Market Share by Manufacturer in 2016
Figure United States Human Coagulation Factor VII Sales Market Share by Manufacturer in 2017
Table United States Human Coagulation Factor VII Revenue by Manufacturer (2016-2017)
Figure United States Human Coagulation Factor VII Revenue Market Share by Manufacturer in 2015
Figure United States Human Coagulation Factor VII Revenue Market Share by Manufacturer in 2016
Table United States Human Coagulation Factor VII Price by Manufacturers (2016-2017)
Figure Top 3 Human Coagulation Factor VII Manufacturer Market Share in 2016
Figure Top 3 Human Coagulation Factor VII Manufacturer Market Share in 2017
Figure Top 5 Human Coagulation Factor VII Manufacturer Market Share in 2016
Figure Top 5 Human Coagulation Factor VII Manufacturer Market Share in 2017
Figure United States Human Coagulation Factor VII Sales and Growth (2012-2017)
Table United States Human Coagulation Factor VII Sales by States (2012-2017)
Table United States Human Coagulation Factor VII Sales Market Share by States (2012-2017)
Figure United States 2012 Human Coagulation Factor VII Sales Market Share by States
Figure United States 2016 Human Coagulation Factor VII Sales Market Share by States
Figure United States Human Coagulation Factor VII Revenue and Growth (2012-2017)
Table United States Human Coagulation Factor VII Revenue by States (2012-2017)
Table United States Human Coagulation Factor VII Revenue Market Share by States (2012-2017)
Table United States 2012 Human Coagulation Factor VII Revenue Market Share by States
Table United States 2016 Human Coagulation Factor VII Revenue Market Share by States
Table United States Human Coagulation Factor VII Sales by Type (2012-2017)
Table United States Human Coagulation Factor VII Sales Share by Type (2012-2017)
Table United States Human Coagulation Factor VII Revenue by Type (2012-2017)
Table United States Human Coagulation Factor VII Revenue Share by Type (2012-2017)
Figure United States Type 1 Sales Growth (2012-2017)
Figure United States Type 1 Price (2012-2017)
Figure United States Type 2 Sales Growth (2012-2017)
Figure United States Type 2 Price (2012-2017)
Table United States Human Coagulation Factor VII Sales by Application (2012-2017)
Table United States Human Coagulation Factor VII Sales Share by Application (2012-2017)
Figure United States Hemophilia Treatment Sales Growth (2012-2017)
Figure United States Surgery Sales Growth (2012-2017)
Figure United States Other Sales Growth (2012-2017)
Figure California Human Coagulation Factor VII Revenue and Growth (2012-2017)
Figure California Human Coagulation Factor VII Sales and Growth (2012-2017)
Table California Human Coagulation Factor VII Sales by Type (2012-2017)
Table California Human Coagulation Factor VII Sales Market Share by Type (2012-2017)
Table California Human Coagulation Factor VII Sales by Application (2012-2017)
Table California Human Coagulation Factor VII Sales Market Share by Application (2012-2017)
Figure New York Human Coagulation Factor VII Revenue and Growth (2012-2017)
Figure New York Human Coagulation Factor VII Sales and Growth (2012-2017)
Table New York Human Coagulation Factor VII Sales by Type (2012-2017)
Table New York Human Coagulation Factor VII Sales Market Share by Type (2012-2017)
Table New York Human Coagulation Factor VII Sales by Application (2012-2017)
Table New York Human Coagulation Factor VII Sales Market Share by Application (2012-2017)
Figure Texas Human Coagulation Factor VII Revenue and Growth (2012-2017)
Figure Texas Human Coagulation Factor VII Sales and Growth (2012-2017)
Table Texas Human Coagulation Factor VII Sales by Type (2012-2017)
Table Texas Human Coagulation Factor VII Sales Market Share by Type (2012-2017)
Table Texas Human Coagulation Factor VII Sales by Application (2012-2017)
Table Texas Human Coagulation Factor VII Sales Market Share by Application (2012-2017)
Figure Florida Human Coagulation Factor VII Revenue and Growth (2012-2017)
Figure Florida Human Coagulation Factor VII Sales and Growth (2012-2017)
Table Florida Human Coagulation Factor VII Sales by Type (2012-2017)
Table Florida Human Coagulation Factor VII Sales Market Share by Type (2012-2017)
Table Florida Human Coagulation Factor VII Sales by Application (2012-2017)
Table Florida Human Coagulation Factor VII Sales Market Share by Application (2012-2017)
Figure Illinois Human Coagulation Factor VII Revenue and Growth (2012-2017)
Figure Illinois Human Coagulation Factor VII Sales and Growth (2012-2017)
Table Illinois Human Coagulation Factor VII Sales by Type (2012-2017)
Table Illinois Human Coagulation Factor VII Sales Market Share by Type (2012-2017)
Table Illinois Human Coagulation Factor VII Sales by Application (2012-2017)
Table Illinois Human Coagulation Factor VII Sales Market Share by Application (2012-2017)
Figure United States Human Coagulation Factor VII Sales, Revenue and Growth Rate (2017-2022)
Table United States Human Coagulation Factor VII Sales Forecast by States (2017-2022)
Table United States Human Coagulation Factor VII Market Share Forecast by States (2017-2022)
Table United States Human Coagulation Factor VII Sales Forecast by Type (2017-2022)
Table United States Human Coagulation Factor VII Market Share Forecast by Type (2017-2022)
Table United States Human Coagulation Factor VII Sales Forecast by Application (2017-2022)
Table United States Human Coagulation Factor VII Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Coagulation Factor VII
Figure Manufacturing Process Analysis of Human Coagulation Factor VII
Figure Human Coagulation Factor VII Industrial Chain Analysis
Table Raw Materials Sources of Human Coagulation Factor VII Major Manufacturers in 2016
Table Major Buyers of Human Coagulation Factor VII
Table Distributors/Traders/ Dealers List